COVID-19 Support

Post

Precision Tools for your COVID-19 Workflow

To support labs pivoting to COVID-19 research, Gemini Bio is prioritizing products and services to assist its customers in these key areas: (1) cell culture, (2) research tools, and (3) analytical instruments.

Cell Culture Viral Harvesting/Transport Research Tools Analytical Instruments
Human Serum Viral Transport Media (Bulk or Custom Fill Sizes) Cryostorage Medium Moxi GO II Cell Analyzer
Gamma-Irradiated Fetal Bovine Serum Saline and PBS Growth Factors Moxi V Cell Analyzer
Custom Media Amphotericin B and Gentamicin Cytokines Moxi Z Cell Counter
Enzymatic Dissociation Hanks’ Balanced Salt Solution (Bulk or Custom Fill Sizes) Albumins  
Bioreactor Solutions Sterile Conical Tubes & Pipettors    
Announcement

Gemini Bio Wins Federal Contract to Support COVID-19 Testing

* Will be increasing domestic production of reagents from its California facility, as well as its manufacturing footprint​

WEST SACRAMENTO, CA, June 11, 2020 – Gemini Bioproducts, LLC (“Gemini Bio”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), today announced the receipt of a federal government contract award to supply critical products in support of the high demand for COVID-19 testing.

Announcement

Gemini Bio Announces Its Dedicated Effort to Help Support COVID-19 Research

* Gemini Bio’s Key Products are Supporting the Fight against COVID-19

WEST SACRAMENTO, CA, April 29, 2020 – Gemini Bioproducts, LLC (“Gemini” or “Gemini Bio”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced its effort to help support COVID-19 research.

According to the WHO, there are over 200 countries with 2.9 million confirmed cases and over 202,000 confirmed deaths, as of the time of this release.